title: Rheumatoid arthritis in 2005: which patients should receive TNFalpha antagonists and when? A point of view.
authors.forename: Xavier
authors.initials: X
authors.lastname: Le Loët
authors.forename: Thierry
authors.initials: T
authors.lastname: Lequerré
authors.forename: Olivier
authors.initials: O
authors.lastname: Vittecoq
mesh_terms: D018501:Antirheumatic Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D018579:Patient Selection; D011788:Quality of Life; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D018501:Antirheumatic Agents; D005938:Glucocorticoids; D014409:Tumor Necrosis Factor-alpha